Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 217S · 10 late217 trades$54.77M
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
IBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
BBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
BCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 27 | Tang StanleyDirector | DASHDoorDash, Inc. Open-market sale · 10b5-1 plan | SELL | $822K 4,759 sh | May 6, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 620 sh | May 6, 2026 traded May 4, 2026 |
| 26 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $91K 740 sh | May 6, 2026 traded May 4, 2026 |
| 25 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $3.46M 1.00M sh | May 6, 2026 traded May 5, 2026 |
| 25 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.67M 1.00M sh | May 6, 2026 traded May 6, 2026 |
| 24 | Duffe LuanaEVP, New Energy |  FTITechnipFMC plcOpen-market sale | SELL | $139K 1,870 sh | May 6, 2026 traded May 5, 2026 |
| 23 | Doyle Jonathan JDirector, Hd of Financial Services Group |  PIPRPIPER SANDLER COMPANIESOpen-market sale | SELL | $483K 6,100 sh | May 6, 2026 traded May 5, 2026 |
| 23 | Inrig JulaCHIEF MEDICAL OFFICER |  TVTXTravere Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $900K 20.0K sh | May 6, 2026 traded May 4, 2026 |
| 23 | Schwab-Pomerantz CarolynDirector |  SCHWSCHWAB CHARLES CORPOpen-market sale | SELL | $915K 9,910 sh | May 6, 2026 traded May 5, 2026 |
| 22 | Foff Erin PennockChief Medical Officer |  MPLTMapLight Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $252K 9,180 sh | May 6, 2026 traded May 4, 2026 |
| 22 | Dube Eric MDirector, CHIEF EXECUTIVE OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $989K 22.5K sh | May 6, 2026 traded May 6, 2026 |
| 22 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $254K 8,989 sh | May 6, 2026 traded May 4, 2026 |
| 21 | Doyle Jonathan JDirector, Hd of Financial Services Group | PIPRPIPER SANDLER COMPANIES Open-market sale | SELL | $23K 300 sh | May 6, 2026 traded May 4, 2026 |
| 21 | Haskins James W.Director |  CARECarter Bankshares, Inc.Open-market sale | SELL | $26K 1,000 sh | May 6, 2026 traded May 5, 2026 |
| 20 | Novack Jeffrey AdamSecretary and General Counsel |  CDNACareDx, Inc.Open-market sale | SELL | $56K 2,688 sh | May 6, 2026 traded May 5, 2026 |
| 20 | Maxwell Michael CaseyPresident - Western Hemisphere |  HALHALLIBURTON COOpen-market sale · 10b5-1 plan | SELL | $568K 13.6K sh | May 6, 2026 traded May 5, 2026 |
| 20 | Maxwell Michael CaseyPresident - Western Hemisphere | HALHALLIBURTON CO Open-market sale · 10b5-1 plan | SELL | $285K 6,782 sh | May 6, 2026 traded May 5, 2026 |
| 19 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $248K 9,030 sh | May 6, 2026 traded May 4, 2026 |
| 19 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $155K 5,460 sh | May 6, 2026 traded May 4, 2026 |
| 19 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $111K 3,908 sh | May 6, 2026 traded May 4, 2026 |
| 19 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $463K 15.9K sh | May 6, 2026 traded May 6, 2026 |
| 19 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $271K 9,645 sh | May 6, 2026 traded May 5, 2026 |
| 19 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $131K 4,803 sh | May 6, 2026 traded May 4, 2026 |
| 19 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $279K 9,935 sh | May 6, 2026 traded May 5, 2026 |
| 18 | Matsuda MasaruSee Remarks |  ARQTArcutis Biotherapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $172K 7,372 sh | May 6, 2026 traded May 4, 2026 |
| 17 | Carr DouglasSVP Finance & Operations |  IPSCCentury Therapeutics, Inc.Open-market sale | SELL | $618 264 sh | May 6, 2026 traded May 4, 2026 |
| 17 | Doyle Jonathan JDirector, Hd of Financial Services Group | PIPRPIPER SANDLER COMPANIES Open-market sale | SELL | $24K 300 sh | May 6, 2026 traded May 5, 2026 |
| 16 | Cline Christopher R.CHIEF FINANCIAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $102K 2,181 sh | May 6, 2026 traded May 5, 2026 |
| 16 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $8,750 296 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 700 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Hanson KristopherGeneral Counsel | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $21K 683 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $9,223 312 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Inrig JulaCHIEF MEDICAL OFFICER | TVTXTravere Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $101K 2,174 sh | May 6, 2026 traded May 5, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $60K 2,068 sh | May 6, 2026 traded May 6, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $24K 787 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Foff Erin PennockChief Medical Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $229K 8,152 sh | May 6, 2026 traded May 6, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $9,607 325 sh | May 6, 2026 traded May 4, 2026 |
| 16 | Setia VishwasChief Financial Officer | MPLTMapLight Therapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $238K 8,496 sh | May 6, 2026 traded May 6, 2026 |
| 14 | Porter James RichardDirector, President and CEO |  NUVLNuvalent, Inc.Open-market sale · 10b5-1 plan | SELL | $1.77M 17.4K sh | May 6, 2026 traded May 4, 2026 |
| 14 | Watanabe ToddDirector, See Remarks | ARQTArcutis Biotherapeutics, Inc. Open-market sale · 10b5-1 plan | SELL | $75K 3,172 sh | May 6, 2026 traded May 4, 2026 |